Stock FERVENTSYN6 FERVENT SYNERGIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Fervent Synergies Limited

Equities

FERVENTSYN6

INE258M01011

Market Closed - Bombay S.E.
Other stock markets
 03:30:54 31/05/2024 pm IST 		5-day change 1st Jan Change
16.68 INR +3.86% Intraday chart for Fervent Synergies Limited +7.68% -25.27%
09/05 Fervent Synergies Swings to Loss in Fiscal Q4; Shares Drop 5% MT
09/05 Fervent Synergies Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Fervent Synergies Swings to Loss in Fiscal Q4; Shares Drop 5%
MT
Fervent Synergies Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Fervent Synergies Limited Appoints Nehal Bharat Mehta as Company Secretary and Compliance Officer
CI
Fervent Synergies Limited Announces Resignation of Pooja Sanghavi as Company Secretary / Compliance Officer
CI
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Fervent Synergies Swings to Loss in Fiscal Q4
MT
Fervent Synergies Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
Fervent Pharmaceuticals Commences Virtual at Home Phase 2 Clinical Trial of a Peri- and Post-Menopausal Therapy for Treating Hot Flashes and Night Sweats
CI
Fervent Synergies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
Fervent Synergies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
CI
Fervent Synergies Limited Reports Earnings Results for the First Quarter Ended June 30, 2021
CI
Fervent Synergies' : Net Profit Jumps in Fiscal Q4
MT
Fervent Synergies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FERVENTSYN6 Stock
  4. News Fervent Synergies Limited